Items tagged with Drug-resistant TB
Research led by St. Jude Children’s Research Hospital scientists has produced new versions of an old antibiotic that are active against difficult-to-treat tuberculosis; offers new strategy for overcoming drug resistance
After contact with a teacher diagnosed with multidrug-resistant pulmonary tuberculosis, 31 children developed latent infection, according to recent study results published in The Pediatric Infectious Disease Journal.
PUNE: The state has recorded 155 cases of extensively drug-resistant tuberculosis (XDR-TB) in the last three years. Of the 155 cases, 115 alone were recorded last year. Barring nine cases, most of the patients diagnosed with XDR-TB are from Mumbai (123), Navi Mumbai (25) and Pune district (8).
HIV infection is associated with an increased risk of multi-drug-resistant tuberculosis (MDR-TB), results of a systematic review and meta-analysis published in PLOS ONE show. HIV increased the risk of MDR-TB by 24%. The analysis included 24 separate studies with a total patient population of 93,000. The investigators believe their findings have important implications for TB control programmes in terms of detection, appropriate treatment, infection control and follow-up.
Three quarters of South African patients with extensively drug-resistant (XDR) tuberculosis died within 5 years of treatment, according to results of a 107-patient analysis in three South African provinces. Among people with HIV infection, taking antiretroviral therapy (ART) was independently associated with survival.
The depressed 16-yr-old boy, who was admitted to the Sewri hospital, had told his mother that he had lost all hope of recovering.
"I think if more people knew or understood the gravity of the global TB situation then more people would try to help..." Helen Upperton, Olympic Medallist on raising awareness about TB.
Patients who have multi-drug-resistant tuberculosis andare more likely to live if they get simultaneous treatment for both diseases rather than waiting weeks to start the AIDS treatment, a new study has found.
Russian biotech company Infectex, Ltd., recently announced that it has entered into license agreement with Qurient, Ltd., of Korea for the exclusive rights to develop and market Qurient’s Q203 treatment against Tuberculosis.
HIV & AIDS treatment in practice (HATIP) is a regular email newsletter for healthcare workers and community-based organisations on HIV treatment in resource-limited settings.
Page 1 of 72 · Total posts: 01 2 Last→